Tirzepatide is a groundbreaking pharmaceutical agent for individuals battling type 2 diabetes. As a dual stimulator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide https://mariamawcp456442.nizarblog.com/40901913/tirzepatide-a-new-frontier-in-diabetes-treatment